- Home
- FSEA vs CTOR Comparison
FSEA vs CTOR Comparison
Compare FSEA & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- CTOR
- Stock Information
- Founded
- FSEA 1890
- CTOR 2021
- Country
- FSEA United States
- CTOR United States
- Employees
- FSEA N/A
- CTOR N/A
- Industry
- FSEA Savings Institutions
- CTOR
- Sector
- FSEA Finance
- CTOR
- Exchange
- FSEA Nasdaq
- CTOR NYSE
- Market Cap
- FSEA 53.3M
- CTOR 63.7M
- IPO Year
- FSEA N/A
- CTOR N/A
- Fundamental
- Price
- FSEA $11.31
- CTOR $3.10
- Analyst Decision
- FSEA
- CTOR Buy
- Analyst Count
- FSEA 0
- CTOR 2
- Target Price
- FSEA N/A
- CTOR $6.00
- AVG Volume (30 Days)
- FSEA 5.9K
- CTOR 1.4M
- Earning Date
- FSEA 08-08-2025
- CTOR 08-11-2025
- Dividend Yield
- FSEA N/A
- CTOR N/A
- EPS Growth
- FSEA N/A
- CTOR N/A
- EPS
- FSEA 0.00
- CTOR N/A
- Revenue
- FSEA $16,196,000.00
- CTOR N/A
- Revenue This Year
- FSEA N/A
- CTOR N/A
- Revenue Next Year
- FSEA N/A
- CTOR N/A
- P/E Ratio
- FSEA $1,365.55
- CTOR N/A
- Revenue Growth
- FSEA 97.61
- CTOR N/A
- 52 Week Low
- FSEA $8.60
- CTOR $0.55
- 52 Week High
- FSEA $11.80
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- FSEA 51.70
- CTOR N/A
- Support Level
- FSEA $11.00
- CTOR N/A
- Resistance Level
- FSEA $11.33
- CTOR N/A
- Average True Range (ATR)
- FSEA 0.17
- CTOR 0.00
- MACD
- FSEA -0.01
- CTOR 0.00
- Stochastic Oscillator
- FSEA 60.00
- CTOR 0.00
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.